MedPath

Therapeutic Effects of Neurofeedback in Neurological Disorders

Phase 2
Conditions
Parkinsonism Spinocerebellar Degeneration Stroke(with motor deficit[upper limb impairment/ gait and balance disorder]/ with speech dsyfunction)
Registration Number
JPRN-UMIN000010723
Lead Sponsor
Dept. of Neurology, Osaka University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
117
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria includes: 1) severe cognitive dysfunction (MMSE<20). 2) severe carotid or intracerebral arterial stenosis (ICAstenosis>90% or MCA/ACA/PCA stenosis >75%) 3) Patients with large cortical lesion (> 1/3 of MCA territory). 4) unstable general condition. 5) undiagnosed patients. 6) with poor visual acuity (<0.05) 7) unable to understand examiners' order 8) with severe infection. 9) with scalp dermatitis 10) pregnant or lactating woman 11) being considered not to be enrolled in this study by attending physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath